Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Faron Pharmaceuticals (FARN) Share Price

Price 235.00p on 23-05-2025 at 17:05:12
Change -5.00p -2.08%
Buy 240.00p
Sell 230.00p
Buy / Sell FARN Shares
Last Trade: Buy 1,511.00 at 235.00p
Day's Volume: 23,310
Last Close: 235.00p
Open: 245.00p
ISIN: FI4000153309
Day's Range 232.50p - 245.00p
52wk Range: 89.00p - 259.00p
Market Capitalisation: £262m
VWAP: 240.37035p
Shares in Issue: 112m

Faron Pharmaceuticals (FARN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 1,511 235.00p Ordinary
16:05:53 - 23-May-25
Buy* 515 235.00p Ordinary
15:26:44 - 23-May-25
Buy* 80 235.00p Ordinary
14:34:52 - 23-May-25
Sell* 500 230.00p Ordinary
14:23:44 - 23-May-25
Sell* 263 230.10p Ordinary
14:22:53 - 23-May-25
Sell* 900 232.00p Ordinary
14:02:37 - 23-May-25
Buy* 750 236.00p Ordinary
13:59:41 - 23-May-25
Sell* 2,139 236.50p Ordinary
13:58:38 - 23-May-25
Buy* 389 243.00p Ordinary
13:25:12 - 23-May-25
Sell* 2,760 235.00p Ordinary
13:24:12 - 23-May-25
See more Faron Pharmaceuticals trades

Faron Pharmaceuticals (FARN) Share Price History

Time period:
to
Date Open High Low Close Volume
23rd May 2025 (Fri) 245.00 245.00 232.50 235.00 23,310
22nd May 2025 (Thu) 235.00 245.00 235.00 240.00 22,792
21st May 2025 (Wed) 222.50 223.00 223.00 223.00 26,450
20th May 2025 (Tue) 215.00 221.00 217.50 221.00 20,442
19th May 2025 (Mon) 215.00 215.00 215.00 215.00 5,153
16th May 2025 (Fri) 225.00 220.00 215.00 215.00 12,790
15th May 2025 (Thu) 225.00 225.00 225.00 225.00 10,197
14th May 2025 (Wed) 220.00 225.00 220.00 225.00 10,438
13th May 2025 (Tue) 220.00 220.00 220.00 220.00 6,033
12th May 2025 (Mon) 225.00 225.00 220.00 220.00 21,775
9th May 2025 (Fri) 212.50 230.00 230.00 230.00 29,897
8th May 2025 (Thu) 212.50 212.50 210.00 212.50 2,246
7th May 2025 (Wed) 200.00 215.00 200.00 212.50 27,403
6th May 2025 (Tue) 200.00 200.00 200.00 200.00 1,803
5th May 2025 (Mon) 198.761 198.761 198.761 198.761 0
2nd May 2025 (Fri) 192.50 200.00 186.00 200.00 15,785
1st May 2025 (Thu) 197.50 197.50 191.00 192.50 8,110
30th Apr 2025 (Wed) 205.00 205.00 197.50 197.50 17,672
29th Apr 2025 (Tue) 205.00 205.00 205.00 205.00 20,913
28th Apr 2025 (Mon) 202.00 196.00 196.00 196.00 6,826
See more Faron Pharmaceuticals price history

Faron Pharmaceuticals (FARN) Regulatory News

Date Source Headline
3rd Mar 2025 12:05 pm RNS FDA Grants Orphan Drug Designation
28th Feb 2025 12:00 pm RNS Notice of Annual General Meeting
27th Feb 2025 7:30 am RNS Positive EMA Opinion on Orphan Drug Designation
27th Feb 2025 7:15 am RNS Annual Report 2024 published
27th Feb 2025 7:00 am RNS Financial Statement 1 January to 31 December 2024
19th Feb 2025 10:00 am RNS Notice of Financial Statement and Annual Report
14th Feb 2025 12:00 pm RNS Holding(s) in Company
11th Feb 2025 7:30 am RNS Change of Broker
6th Feb 2025 3:00 pm RNS Holding(s) in Company
6th Feb 2025 7:00 am RNS Results of Oversubscribed Placing
See more Faron Pharmaceuticals regulatory news

Faron Pharmaceuticals (FARN) Share News

IN BRIEF: Faron Pharmaceuticals appoints new chief business officer

21st May 2025 12:41

Faron Pharmaceuticals Ltd - Turku, Finland-based developer of cancer immunotherapies - Appoints Ralph Hughes as chief business officer, effective from next Wednesday. Notes Hughes' prior experience as senior vice president at PharmaVentures, and his extensive experience in commercial due diligence, market access and the business development process. Adds that he will be part of the management team and the business development team. "We are delighted to have such an experienced pharmaceutical market access and strategic commercial development expert to join us as the new CBO", says Chief Executive Juho Jalkanen. "Ralph's proven track record in biopharma leadership and his experience align perfectly with our corporate development efforts and strategic growth initiatives." Read More

UK shareholder meetings calendar - next 7 days

14th Mar 2025 14:09

Read More

UK earnings, trading statements calendar - next 7 days

20th Feb 2025 14:16

Read More

Faron Pharmaceuticals raises EUR12 million from oversubscribed placing

6th Feb 2025 11:41

(Alliance News) - Faron Pharmaceuticals Ltd on Thursday said it has raised EUR12 million from an oversubscribed placing ahead of upcoming trial results. Read More

IN BRIEF: Faron Pharmaceuticals shares up as presents data on Bexmab

10th Dec 2024 14:31

Faron Pharmaceuticals PLC on Tuesday - Turku, Finland-based developer of cancer immunotherapies - Presents full analysis of positive phase 2 interim data from Bexmab trial at the annual meeting of the Society of Hematology in San Diego. Faron highlights an overall response rate of 80% in refractory or relapsed HMA failed MDS patient population. HMA stands for hypomethylating agents, while MDS stands for myelodysplastic syndromes. Chief Executive Officer Juho Jalkanen says: "With this compelling evidence, we are well positioned to advance to the full phase 2 efficacy readout and actively pursue further regulatory interactions to navigate and refine the pivotal pathway for BLA filing." Read More

See more Faron Pharmaceuticals news
FTSE 100 Latest
Value8,717.97
Change-21.29

Login to your account

Forgot Password?

Not Registered